Evidence map›Paper›PMID 26948697›Full record

Trial reportHeart & lung : the journal of critical care

A randomized controlled pilot trial to improve advance care planning for LVAD patients and their surrogates.

Maureen Metzger, Mi-Kyung Song, Sandra Ward, Patricia Pat-Yue Chang, Laura C Hanson, Feng-Chang Lin

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Heart & lung : the journal of critical care. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Advance care planning for adults with heart failure.The Cochrane database of systematic reviews · 2020
    Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Maureen MetzgerUniversity of Virginia School of Nursing, USA. Electronic address: mjm9cd@virginia.edu.
Mi-Kyung SongEmory University Nell Hodgson School of Nursing, USA.
Sandra WardUniversity of Wisconsin-Madison School of Nursing, USA.
Patricia Pat-Yue ChangUniversity of North Carolina at Chapel Hill School of Medicine, USA.
Laura C HansonUniversity of North Carolina at Chapel Hill School of Medicine, USA.
Feng-Chang LinUniversity of North Carolina at Chapel Hill, USA.
University of North Carolina at Chapel Hill · USEmory University · USUniversity of Virginia · USUniversity of Wisconsin–Madison · US

Funding

North Carolina Translational & Clinical Sciences Institute (NC TraCS)UL1TR001111 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, CAREY, TIMOTHY S · 2013 to 2017
$43.9M
INTERVENTIONS FOR PREVENTING &MANAGING CHRONIC ILLNESST32NR007091 · NINR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Cheryl L Giscombe, Cathi Barbra Propper · 1996 to 2026
$11.8M
NCATS NIH HHS UL1 TR001111NINR NIH HHS T32 NR007091
6 · The paper itself

Abstract

objectivesTo examine feasibility, acceptability and preliminary effects of an advance care planning (ACP) intervention, SPIRIT-HF, in LVAD patients and their surrogates.

backgroundLVADs may improve HF symptoms but they are not curative. Thus, ACP is needed to prepare patients and surrogates for end-of-life (EOL) decision-making.

methodsBridge to transplant and destination therapy LVAD patient-surrogate dyads were randomized to either SPIRIT-HF or usual care. Percentages of eligible dyads who were enrolled and completed the study determined feasibility. Analysis of interviews with SPIRIT dyads determined acceptability. Group comparisons of dyad congruence, patient's decisional conflict, and surrogate's decision-making confidence determined preliminary effects.

resultsOf 38 eligible dyads, 29 (76%) were enrolled, randomized, and completed the study. The 14 intervention dyads characterized SPIRIT-HF as beneficial. All dyads demonstrated improvement in outcomes. However, SPIRIT-HF dyads tended toward greater congruence on patient EOL treatment goals.

conclusionsSPIRIT-HF is feasible and acceptable. Results will inform future trials.

Indexed as

Decision MakingHeart-Assist DevicesAdultAdvance Care PlanningAgedAged, 80 and overFeasibility StudiesFemaleHeart FailureHumansMaleMiddle AgedPilot ProjectsRetrospective StudiesTerminal CareAdvance care planning interventionEnd-of-life careFamily membersLVADsSurrogates

Identifiers

PMID26948697
PMCPMC5748890
OpenAlexW2289047064

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.